{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:46:45Z","timestamp":1754153205110,"version":"3.41.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,22]]},"DOI":"10.7759\/cureus.88526","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:18:51Z","timestamp":1753201131000},"source":"Crossref","is-referenced-by-count":0,"title":["Endocrine and Metabolic Challenges of Long-Term Lithium Therapy: Diagnostic and Management Considerations"],"prefix":"10.7759","author":[{"given":"Stylianos","family":"Kopanos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Feldkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcp.2017.01.003","article-title":"Endocrinological disorders related to the medical use of lithium. A narrative review","volume":"48","author":"Garc\u00eda-Maldonado G","year":"2019","unstructured":"Garc\u00eda-Maldonado G, Castro-Garc\u00eda RJ. Endocrinological disorders related to the medical use of lithium. A narrative review. Rev Colomb Psiquiatr (Engl Ed). 2019, 48:35-43. 10.1016\/j.rcp.2017.01.003","journal-title":"Rev Colomb Psiquiatr (Engl Ed)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4158\/EP10273.RA","article-title":"Lithium use and primary hyperparathyroidism","volume":"17","author":"Broome JT","year":"2011","unstructured":"Broome JT, Solorzano CC. Lithium use and primary hyperparathyroidism. Endocr Pract. 2011, 17:31-5. 10.4158\/EP10273.RA","journal-title":"Endocr Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.06.046","article-title":"Lithium-associated hyperparathyroidism and hypercalcaemia: a case-control cross-sectional study","volume":"151","author":"Albert U","year":"2013","unstructured":"Albert U, De Cori D, Aguglia A, Barbaro F, Lanfranco F, Bogetto F, Maina G. Lithium-associated hyperparathyroidism and hypercalcaemia: a case-control cross-sectional study. J Affect Disord. 2013, 151:786-90. 10.1016\/j.jad.2013.06.046","journal-title":"J Affect Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-016-0068-y","article-title":"Lithium side effects and toxicity: prevalence and management strategies","volume":"4","author":"Gitlin M","year":"2016","unstructured":"Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord. 2016, 4:27. 10.1186\/s40345-016-0068-y","journal-title":"Int J Bipolar Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-022-00283-3","article-title":"Lithium induced hypercalcemia: an expert opinion and management algorithm","volume":"10","author":"Kovacs Z","year":"2022","unstructured":"Kovacs Z, Vestergaard P, Licht RW, et al.. Lithium induced hypercalcemia: an expert opinion and management algorithm. Int J Bipolar Disord. 2022, 10:34. 10.1186\/s40345-022-00283-3","journal-title":"Int J Bipolar Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/2194-7511-1-7","article-title":"Do current screening recommendations allow for early detection of lithium-induced hyperparathyroidism in patients with bipolar disorder?","volume":"1","author":"Berger M","year":"2013","unstructured":"Berger M, Riedel M, Tomova N, et al.. Do current screening recommendations allow for early detection of lithium-induced hyperparathyroidism in patients with bipolar disorder?. Int J Bipolar Disord. 2013, 1:7. 10.1186\/2194-7511-1-7","journal-title":"Int J Bipolar Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1999.00977.x","article-title":"Pathology and outcome of surgical treatment for lithium-associated hyperparathyroidism","volume":"86","author":"Abdullah H","year":"1999","unstructured":"Abdullah H, Bliss R, Guinea AI, Delbridge L. Pathology and outcome of surgical treatment for lithium-associated hyperparathyroidism. Br J Surg. 1999, 86:91-3. 10.1046\/j.1365-2168.1999.00977.x","journal-title":"Br J Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.3170","article-title":"Lithium treatment in the prevention of repeat suicide-related outcomes in veterans with major depression or bipolar disorder: a randomized clinical trial","volume":"79","author":"Katz IR","year":"2022","unstructured":"Katz IR, Rogers MP, Lew R, et al.. Lithium treatment in the prevention of repeat suicide-related outcomes in veterans with major depression or bipolar disorder: a randomized clinical trial. JAMA Psychiatry. 2022, 79:24-32. 10.1001\/jamapsychiatry.2021.3170","journal-title":"JAMA Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnf.0000150871.52253.b7","article-title":"The syndrome of irreversible lithium-effectuated neurotoxicity","volume":"28","author":"Adityanjee","year":"2005","unstructured":"Adityanjee, Munshi KR, Thampy A. The syndrome of irreversible lithium-effectuated neurotoxicity. Clin Neuropharmacol. 2005, 28:38-49. 10.1097\/01.wnf.0000150871.52253.b7","journal-title":"Clin Neuropharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5152\/alphapsychiatry.2024.231460","article-title":"The syndrome of irreversible lithium-effectuated neurotoxicity: a scoping review","volume":"25","author":"Konieczny K","year":"2024","unstructured":"Konieczny K, Detraux J, Bouckaert F. The syndrome of irreversible lithium-effectuated neurotoxicity: a scoping review. Alpha Psychiatry. 2024, 25:190-205. 10.5152\/alphapsychiatry.2024.231460","journal-title":"Alpha Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00197.2011","article-title":"Lithium reduces aquaporin-2 transcription independent of prostaglandins","volume":"302","author":"Kortenoeven ML","year":"2012","unstructured":"Kortenoeven ML, Schweer H, Cox R, Wetzels JF, Deen PM. Lithium reduces aquaporin-2 transcription independent of prostaglandins. Am J Physiol Cell Physiol. 2012, 302:C131-40. 10.1152\/ajpcell.00197.2011","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117863","article-title":"Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla","volume":"95","author":"Marples D","year":"1995","unstructured":"Marples D, Christensen S, Christensen EI, Ottosen PD, Nielsen S. Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest. 1995, 95:1838-45. 10.1172\/JCI117863","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01640408","article-title":"Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride","volume":"3","author":"Bedford JJ","year":"2008","unstructured":"Bedford JJ, Weggery S, Ellis G, McDonald FJ, Joyce PR, Leader JP, Walker RJ. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride. Clin J Am Soc Nephrol. 2008, 3:1324-31. 10.2215\/CJN.01640408","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-020-00517-2","article-title":"Triamterene in lithium-induced nephrogenic diabetes insipidus: a case report","volume":"10","author":"Inoue M","year":"2021","unstructured":"Inoue M, Nakai K, Mitsuiki K. Triamterene in lithium-induced nephrogenic diabetes insipidus: a case report. CEN Case Rep. 2021, 10:64-8. 10.1007\/s13730-020-00517-2","journal-title":"CEN Case Rep"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.4103\/1947-2714.161252","article-title":"Lithium-induced minimal change disease and acute kidney injury","volume":"7","author":"Tandon P","year":"2015","unstructured":"Tandon P, Wong N, Zaltzman JS. Lithium-induced minimal change disease and acute kidney injury. N Am J Med Sci. 2015, 7:328-31.","journal-title":"N Am J Med Sci"},{"key":"ref16","article-title":"Hyperparathyroidism with lithium [Article in French]","volume":"20","author":"Brochier  T","year":"1994","unstructured":"Brochier  T, Adnet-Kessous J, Barillot M, Pascalis JG. Hyperparathyroidism with lithium [Article in French]. Encephale. 1994, 20:339-49.","journal-title":"Encephale"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4158\/EP.12.1.54","article-title":"Reversible hypercalcemia and hyperparathyroidism associated with lithium therapy: case report and review of literature","volume":"12","author":"Khandwala HM","year":"2006","unstructured":"Khandwala HM, Van Uum S. Reversible hypercalcemia and hyperparathyroidism associated with lithium therapy: case report and review of literature. Endocr Pract. 2006, 12:54-8. 10.4158\/EP.12.1.54","journal-title":"Endocr Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/1039856214555891","article-title":"Nephrotic syndrome and acute kidney injury in a patient treated with lithium carbonate","volume":"22","author":"Zieg J","year":"2014","unstructured":"Zieg J, Simankova N, Hradsky O, Hacek J, Hribal Z. Nephrotic syndrome and acute kidney injury in a patient treated with lithium carbonate. Australas Psychiatry. 2014, 22:591-2. 10.1177\/1039856214555891","journal-title":"Australas Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2022.01.001","article-title":"What an endocrinologist should know for patients receiving lithium therapy","volume":"83","author":"Haissaguerre M","year":"2022","unstructured":"Haissaguerre M, Vantyghem MC. What an endocrinologist should know for patients receiving lithium therapy. Ann Endocrinol (Paris). 2022, 83:219-25. 10.1016\/j.ando.2022.01.001","journal-title":"Ann Endocrinol (Paris)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-017-4328-5","article-title":"Lithium-associated hypercalcemia: pathophysiology, prevalence, management","volume":"42","author":"Meehan AD","year":"2018","unstructured":"Meehan AD, Udumyan R, Kardell M, Land\u00e9n M, J\u00e4rhult J, Wallin G. Lithium-associated hypercalcemia: pathophysiology, prevalence, management. World J Surg. 2018, 42:415-24. 10.1007\/s00268-017-4328-5","journal-title":"World J Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/381100-endocrine-and-metabolic-challenges-of-long-term-lithium-therapy-diagnostic-and-management-considerations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:18:52Z","timestamp":1753201132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/381100-endocrine-and-metabolic-challenges-of-long-term-lithium-therapy-diagnostic-and-management-considerations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.88526","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,22]]}}}